![James Oliviero](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Oliviero
Direktor/Vorstandsmitglied bei
NUVECTIS PHARMA, INC.
Vermögen: 2 Mio $ am 30.06.2026
Profil
James F.
Oliviero is an Independent Director at Nuvectis Pharma, Inc. since 2021.
Formerly, Mr. Oliviero was President, Chief Executive Officer & Director at Checkpoint Therapeutics, Inc. from 2018 to 2025.
Mr. Oliviero was Finance Director at ACCESS Oncology, Inc. from 1999 to 2003.
Mr. Oliviero was Chief Financial Officer & Treasurer at Keryx Biopharmaceuticals, Inc. in 2015.
Mr. Oliviero completed undergraduate studies at Goizueta Business School-Emory.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 0,46 % | 11.06.2026 | 122.828 ( 0,46 % ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von James Oliviero
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVECTIS PHARMA, INC. | Direktor/Vorstandsmitglied | 01.07.2021 |
Ehemalige bekannte Positionen von James Oliviero
| Unternehmen | Position | Ende |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Vorstandsvorsitzender | 30.05.2025 |
| KERYX BIOPHARMACEUTICALS | Finanzdirektor/CFO | 01.09.2015 |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Finanzdirektor/CFO | 01.05.2003 |
Ausbildung von James Oliviero
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
